Enrolling by invitationNCT05998291

Dermatitis Herpetiformis Refractory to Gluten Free Diet

Studying Dermatitis herpetiformis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Tampere University Hospital
Principal Investigator: Kaisa Hervonen, PhD
Tampere University Hospital
Intervention: Assessment of prognosis of refractory dermatitis herpetiformis. No intervention(other)
Enrollment: 23 enrolled
Eligibility: 18 years · All sexes
Timeline: 2023 – 2026

Study locations (1)

Tampere University Hospital, Tampere, Finland

Collaborators

Tampere University · University of Helsinki

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05998291 on ClinicalTrials.gov

Other trials for Dermatitis herpetiformis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT05597904
Background of Different Phenotypes of Coeliac Disease
Tampere University Hospital

See all trials for Dermatitis herpetiformis →

← Back to all trials